$MDCO News Article - The Medicines Company Announces that the ORION-9 Study of Inclisiran in HeFH Patients Showed Durable and Potent LDL-C Lowering with Twice-Yearly Dosing https://marketwirenews.com/news-releases/the-...89733.html